Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2,3-d]pyrimidines

Details for Australian Patent Application No. 2006213033 (hide)

Owner Duquesne University of the Holy Ghost

Inventors Gangjee, Aleem

Agent Pizzeys

Pub. Number AU-B-2006213033

PCT Pub. Number WO2006/086144

Priority 11/055,732 10.02.05 US

Filing date 23 January 2006

Wipo publication date 17 August 2006

Acceptance publication date 16 February 2012

International Classifications

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/086144 Priority application(s): WO2006/086144

16 February 2012 Application Accepted

  Published as AU-B-2006213033

14 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213039-Phuman T2R receptors for acetaminophen, ranitidine, strychnine and denatonium and related assays for identifying human bitter taste modulators

2006213013-Valve assembly